Business Description
Roivant Sciences is a London-based biopharmaceutical company founded in 2014 that discovers, develops, and brings to market new medicines and drug delivery technologies. The company is advancing several treatment candidates targeting autoimmune and inflammatory conditions such as rheumatoid arthritis, lupus, and myasthenia gravis, as well as pulmonary hypertension linked to lung disease. Roivant also develops platforms designed to improve how medicines are delivered into the body.
